We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$123B
1-Year Est. Return
34.51%
This Fund
S&P 500
This Quarter
Est. Return
+8.84%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$82.9B
AUM Growth
+$1.82B
(+2.3%)
Cap. Flow
-$3.2B
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
27.48%
Holding
1,503
New
58
Increased
633
Reduced
567
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$256M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$156M |
| 4 |
Franco-Nevada
FNV
|
+$115M |
| 5 |
NVIDIA
NVDA
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Pacific Kansas City
CP
|
+$990M |
| 2 |
Pfizer
PFE
|
+$226M |
| 3 |
Amazon
AMZN
|
+$224M |
| 4 |
Johnson & Johnson
JNJ
|
+$220M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$220M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Financials | 19.43% |
| 3 | Healthcare | 10.94% |
| 4 | Consumer Discretionary | 8.03% |
| 5 | Communication Services | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Lam Research
LRCX
$367B
| $125M | 0.15% |
2,352,630
-273,580
| -10% | -$13.4M |
|
127
Wheaton Precious Metals
WPM
$49.5B
| $125M | 0.15% |
2,590,276
+22,151
| +0.9% | +$968K |
|
128
Vertex Pharmaceuticals
VRTX
$121B
| $122M | 0.15% |
386,586
+6,572
| +2% | +$1.97M |
|
129
Teleflex
TFX
$6.05B
| $121M | 0.15% |
479,460
-34,078
| -7% | -$8.26M |
|
130
Bank of America
BAC
$435B
| $121M | 0.15% |
4,230,466
-2,695,604
| -39% | -$89M |
|
131
Salesforce
CRM
$151B
| $120M | 0.14% |
598,507
-2,023
| -0.3% | -$342K |
|
132
Adobe
ADBE
$99.5B
| $119M | 0.14% |
309,029
+16,256
| +6% | +$5.78M |
|
133
S&P Global
SPGI
$121B
| $117M | 0.14% |
338,975
-27,091
| -7% | -$9.53M |
|
134
Ingersoll Rand
IR
$32.6B
| $115M | 0.14% |
1,980,367
-83,101
| -4% | -$4.68M |
|
135
Applied Materials
AMAT
$403B
| $114M | 0.14% |
930,314
+12,733
| +1% | +$1.46M |
|
136
Amgen
AMGN
$208B
| $110M | 0.13% |
456,115
+4,734
| +1% | +$1.16M |
|
137
State Street Technology Select Sector SPDR ETF
XLK
$115B
| $110M | 0.13% |
1,457,400
| – | – |
|
138
Bruker
BRKR
$9.57B
| $110M | 0.13% |
1,390,353
-170,892
| -11% | -$12.3M |
|
139
Liberty Media Series C
FWONK
$24.6B
| $109M | 0.13% |
1,501,988
-17,218
| -1% | -$1.16M |
|
140
Yum! Brands
YUM
$41.8B
| $108M | 0.13% |
814,838
+89,662
| +12% | +$11.5M |
|
141
AstraZeneca
AZN
$263B
| $106M | 0.13% |
765,485
-43,488
| -5% | -$5.85M |
|
142
Goldman Sachs
GS
$300B
| $106M | 0.13% |
323,609
-257,458
| -44% | -$89.6M |
|
143
Medtronic
MDT
$109B
| $104M | 0.13% |
1,284,858
+119,984
| +10% | +$9.78M |
|
144
MongoDB
MDB
$27.1B
| $103M | 0.12% |
443,691
-264,629
| -37% | -$55.5M |
|
145
Arthur J. Gallagher & Co
AJG
$64.1B
| $103M | 0.12% |
539,910
+178,617
| +49% | +$33.9M |
|
146
Bristol-Myers Squibb
BMY
$133B
| $103M | 0.12% |
1,482,002
+135,533
| +10% | +$9.56M |
|
147
Colgate-Palmolive
CL
$73.1B
| $102M | 0.12% |
1,356,122
-15,530
| -1% | -$1.15M |
|
148
Air Products & Chemicals
APD
$65.7B
| $101M | 0.12% |
351,803
-3,835
| -1% | -$1.12M |
|
149
SLB Ltd
SLB
$73.6B
| $101M | 0.12% |
2,055,510
+1,581,230
| +333% | +$84M |
|
150
Automatic Data Processing
ADP
$106B
| $98.2M | 0.12% |
441,208
+7,274
| +2% | +$1.64M |
|
Similar funds
VAM
TD Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, TD Asset Management held 1,503 positions worth $82.9B, up 2.3% from $81B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
TD Asset Management withdrew a net $3.2B in Q1 2023, closing 76 positions and reducing 567 holdings. Its most notable exit was Canadian Pacific Kansas City, an estimated $990M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, TD Asset Management opened a new position in Novo Nordisk worth $25.2M.
- TD Asset Management's largest Q1 2023 buy was Novo Nordisk: 316,140 shares worth $25.2M.
- TD Asset Management added most to Merck in Q1 2023, an estimated $256M increase.
- TD Asset Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $226M.
- TD Asset Management fully exited Canadian Pacific Kansas City in Q1 2023, selling an estimated $990M.
- TD Asset Management's ten largest holdings make up 27% of its $82.9B portfolio in Q1 2023.
- TD Asset Management opened 58 new positions and closed 76 in Q1 2023.
- TD Asset Management's portfolio value rose 2.3% quarter-over-quarter to $82.9B.
Based on TD Asset Management's 13F filing for Q1 2023, filed 10 May 2023.